# IMRT/Pemetrexed/Cisplatin in Esophageal Cancer

> **NCT01630174** · — · UNKNOWN · sponsor: **Shandong Cancer Hospital and Institute** · enrollment: 30 (estimated)

## Conditions studied

- Esophageal Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01630174
- **Lead sponsor:** Shandong Cancer Hospital and Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-10
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2012-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01630174

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01630174, "IMRT/Pemetrexed/Cisplatin in Esophageal Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01630174. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*